UBS Group’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-15,787
| Closed | -$176K | – | 10105 |
|
|
2022
Q4 | $176K | Buy |
15,787
+13,123
| +493% | +$147K | ﹤0.01% | 4471 |
|
|
2022
Q3 | $15K | Buy |
2,664
+417
| +19% | +$2.35K | ﹤0.01% | 6780 |
|
|
2022
Q2 | $10K | Buy |
2,247
+1,249
| +125% | +$5.56K | ﹤0.01% | 7039 |
|
|
2022
Q1 | $12K | Sell |
998
-2,600
| -72% | -$31.3K | ﹤0.01% | 7202 |
|
|
2021
Q4 | $66K | Buy |
+3,598
| New | +$66K | ﹤0.01% | 5589 |
|
|
2021
Q3 | – | Sell |
-829
| Closed | -$14K | – | 9105 |
|
|
2021
Q2 | $14K | Sell |
829
-816
| -50% | -$13.8K | ﹤0.01% | 6639 |
|
|
2021
Q1 | $30K | Sell |
1,645
-19
| -1% | -$347 | ﹤0.01% | 6014 |
|
|
2020
Q4 | $31K | Buy |
1,664
+750
| +82% | +$14K | ﹤0.01% | 5613 |
|
|
2020
Q3 | $20K | Sell |
914
-2,993
| -77% | -$65.5K | ﹤0.01% | 5453 |
|
|
2020
Q2 | $113K | Buy |
3,907
+633
| +19% | +$18.3K | ﹤0.01% | 4397 |
|
|
2020
Q1 | $115K | Sell |
3,274
-3,681
| -53% | -$129K | ﹤0.01% | 4320 |
|
|
2019
Q4 | $170K | Buy |
+6,955
| New | +$170K | ﹤0.01% | 4692 |
|